HIVEP1

HIVEP1 Full Name

human immunodeficiency virus type I enhancer binding protein 1

HIVEP1 Introduction

HIVEP1 (human immunodeficiency virus enhancer-binding protein 1) is a large zinc-finger transcription factor belonging to the HIVEP family, which also includes HIVEP2 and HIVEP3. These proteins are characterized by multiple ZAS (zinc finger–associated sequence) domains that confer sequence-specific DNA-binding capacity, nuclear localization, and regulatory versatility. Early molecular characterization of HIVEP family members, including comparative work in Xenopus and Drosophila Schnurri homologs, established a conserved domain architecture linking HIVEP proteins to transcriptional control across inflammatory and developmental pathways. In particular, homology with Drosophila Schnurri connected the family to TGF-β/Dpp signaling, while mammalian studies implicated HIVEP proteins in TNF-α–related and immune-responsive gene regulation. Historically, HIVEP1 was identified in the context of binding enhancer elements within the long terminal repeat (LTR) of Human immunodeficiency virus 1, situating it within NF-κB–related transcriptional landscapes. Collectively, structural and evolutionary evidence positions HIVEP1 as a conserved, multi–zinc-finger transcription factor capable of integrating inflammatory and developmental signals through direct promoter and enhancer interactions.

More recent functional studies have clarified HIVEP1's mechanistic role within NF-κB signaling networks. In monocytes and macrophages, HIVEP1 acts as a negative regulator of NF-κB–driven transcription. It binds κB motif–containing promoter regions of inflammatory genes and restrains transcriptional activation in response to stimuli such as lipopolysaccharide (LPS). Loss-of-function experiments demonstrate that HIVEP1 deficiency enhances proinflammatory cytokine production, indicating that HIVEP1 serves as a transcriptional brake that tempers excessive innate immune activation. Mechanistically, this regulatory effect appears to derive from promoter occupancy and competition or modulation at κB-responsive elements, thereby constraining NF-κB–dependent gene expression programs. These findings integrate earlier motif-binding observations with direct in vitro and in vivo evidence, supporting a coherent model in which HIVEP1 modulates, rather than simply supports, NF-κB activity. Importantly, this regulatory function appears context dependent: while current evidence emphasizes repression in myeloid inflammatory settings, the broader transcription factor paradigm suggests that HIVEP1's activity may vary depending on promoter architecture, chromatin context, interacting cofactors, and cellular lineage.

In vivo models reinforce the physiological relevance of HIVEP1-mediated regulation. Macrophages derived from HIVEP1-deficient mice display exaggerated cytokine responses following inflammatory challenge, consistent with a loss of negative control over NF-κB signaling. Complementary evidence from zebrafish models supports evolutionary conservation of this anti-inflammatory role, with HIVEP1 perturbation altering host responses to bacterial infection. Together, these data underscore HIVEP1 as a conserved modulator of innate immunity with potential implications for systemic inflammatory conditions such as sepsis. While no strong contradictory evidence currently defines a dominant proinflammatory function in the contexts examined, important gaps remain: genome-wide binding landscapes, stimulus-specific regulatory switching, and potential cross-talk with TGF-β or other transcriptional programs require further delineation. Overall, the literature supports a synthesis in which HIVEP1 is a structurally conserved zinc-finger transcription factor that binds κB-related motifs and acts predominantly as a negative regulator of NF-κB–driven inflammation in myeloid cells, with cross-species validation and emerging translational relevance for inflammatory disease modulation.

Alternate Names for HIVEP1

HIVEP1; human immunodeficiency virus type I enhancer binding protein 1; human immunodeficiency virus type I enhancer binding protein 1; zinc finger protein 40; ZNF40; zinc finger protein 40; CIRIP; CRYBP1; MBP 1; PRDII BF1

View more

• 1. Dürr U., et al. Isolation and characterization of the Xenopus HIVEP gene family. European Journal of Biochemistry. 2004;271(6):1135–1144.
  2. Garcia J., et al. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. The EMBO Journal. 1987;6(12):3761–3770.
  3. K?rner M., et al. Characterization of the human immunodeficiency virus type 1 enhancer-binding proteins from the human T-cell line Jurkat. Biochemical Journal. 1990;265(2):547–554.
  4. Matsumoto H., et al. HIVEP1 Is a Negative Regulator of NF-κB That Inhibits Systemic Inflammation in Sepsis. Frontiers in Immunology. 2021;12.
  5. Orchard K., et al. A novel T-cell protein which recognizes a palindromic sequence in the negative regulatory element of the human immunodeficiency virus long terminal repeat. Journal of Virology. 1990;64(7):3234–3239.